Skip to main content
About
Company Overview
Corporate Policies
Governance Policies
Team
Partners
Careers
Research
Clinical Trials
Publications
Pipeline
Investors
Newsroom
Contact
Facebook
Twitter
Linkedin
MENU
Home
About
Company Overview
Team
Partners
Careers
Patient Resource
Pipeline
Investors
Newsroom
Contact
Home
Investors
Overview
Events and Presentations
Stock Info
Financials
Governance
Board of Directors
Executive Management
Committee Composition
Resources
Shareholder Info
FAQs
Email Alerts
Newsroom
Press Releases
Videos
Press Releases
Home
Investors
Overview
Events and Presentations
Stock Info
Financials
Governance
Board of Directors
Executive Management
Committee Composition
Resources
Shareholder Info
FAQs
Email Alerts
Newsroom
Press Releases
Videos
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
12/06/2016
Tetra Bio-Pharma Looks to Make Cannabis Affordable
12/06/2016
Aphria Makes $1,000,000 Investment in Tetra Bio-Pharma Via Private Placement to Fund Phyto Pain Pharma Clinical Trials
Download
PDF format download (opens in new window)
11/23/2016
Tetra Bio-Pharma Provides USA Regulatory Update for its Cannabis Inhalation Product PPP001
Download
PDF format download (opens in new window)
11/21/2016
Tetra Bio-Pharma (GRPOF) Pioneers a New, Ancient Approach to Cannabinoid Delivery
11/16/2016
Tetra Bio-Pharma Achieves DTC Eligibility in the United States
Download
PDF format download (opens in new window)
11/14/2016
Tetra Bio-Pharma (GRPOF) Pioneers a New, Ancient Approach to Cannabinoid Delivery
11/04/2016
Tetra Bio-Pharma Inc. Announces the Closing of $914,456 Non-Brokered Private Placement
Download
PDF format download (opens in new window)
11/03/2016
Tetra Bio-Pharma Enters into Medical Cannabis Supply Agreement With ACMPR Licensed Producer Aphria Inc.
Download
PDF format download (opens in new window)
11/02/2016
Tetra Bio-Pharma Announces Outcome of its Meeting with its Scientific and Clinical Advisory Board
Download
PDF format download (opens in new window)
10/26/2016
Tetra Bio-Pharma Announces Acquisition of Intellectual Property for the Development of Natural Health Products Through its Agro-Tek Subsidiary
Download
PDF format download (opens in new window)
10/20/2016
Tetra Bio-Pharma Inc. Announces a $750,000 Non-brokered Private Placement & Granting of Options
Download
PDF format download (opens in new window)
10/19/2016
Tetra BioPharma Announces Awarding of NSERC Engage Grant partnership to Grow Pros MMP and McGill University
Download
PDF format download (opens in new window)
10/07/2016
Tetra Bio-Pharma Secures $2M Equity Facility from New York Private Equity Firm
Download
PDF format download (opens in new window)
10/04/2016
Tetra Bio-Pharma Inc. Announces Its Pre-IND Meeting with FDA was Granted
Download
PDF format download (opens in new window)
10/04/2016
Tetra Bio-Pharma Inc. annonce que sa demande de rencontre préalable (dite « pre-IND ») relative à son nouveau médicament de recherche a été acceptée
Download
PDF format download (opens in new window)
09/29/2016
Tetra Bio-Pharma Inc. Announces That its Phase I Trial of Inhaled Marijuana in Healthy Volunteers Will Be Performed by Algorithme Pharma, an Altasciences Company
Download
PDF format download (opens in new window)
09/29/2016
Tetra Bio-Pharma Inc. annonce que l’essai clinique de phase I sur la marijuana inhalée chez des volontaires en santé sera mené par Algorithme Pharma, une société membre d’Altasciences
Download
PDF format download (opens in new window)
09/26/2016
PhytoPain Pharma Provides USA Regulatory Update for its Cannabis Inhalation Product PPP001
Download
PDF format download (opens in new window)
09/22/2016
PhytoPain Pharma annonce une entrevue avec Radio-Canada sur un médicament d’ordonnance à base de marijuana qu’elle met au point
Download
PDF format download (opens in new window)
09/22/2016
PhytoPain Pharma Announces Interview with Radio-Canada regarding its Development of a Prescription Marijuana Drug
Download
PDF format download (opens in new window)
09/06/2016
GCI Subsiduary PhytoPain Pharma Announces Submission of Orphan Drug Designation Application for Delta-9-tetrahydrocannibinol and Cannabidiol in the United States
Download
PDF format download (opens in new window)
08/26/2016
PhytoPain Pharma Announces Appointments to its Scientific and Clinical Advisory Board
Download
PDF format download (opens in new window)
08/25/2016
GROWPROS Announces Details of AGM
Download
PDF format download (opens in new window)